Tufia Christine Haddad MD

Breast Cancer, Clinical Informatics

Professor, Oncology, Mayo Clinic School of Graduate Medical Education

200 1st St SWRochester, MN 55905
Phone+1 507-284-2511

Dr. Haddad is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Haddad's full profile Already have an account?

Education & Training

University of MinnesotaFellowship, Hematology and Medical Oncology, 2004 - 2007
Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 2001 - 2004
Creighton University School of MedicineClass of 2001
Marquette UniversityB.S., Biology, Magna Cum Laude, 1991 - 1995

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

MN State Medical License 2002 - 2027
SD State Medical License Active through 2027
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

HIMSS Future50 Clinical Leader Health Information and Management Systems Society, 2021
CMS Meaningful Use Stage 2 Certification Mayo Clinic Electronic Notes, Mayo Clinic, 2014-2017
CMS Meaningful Use Stage 1 Certification Centricity Patient Online, GE Healthcare, 2014-2017

Clinical Trials

Capecitabine and Lapatinib Ditosylate With or Without Cixutumumab in Treating Patients With Previously Treated HER2-Positive Stage IIIB-IV Breast Cancer Start of enrollment: 2008 Jul 30
COMPLETED
PHASE2
Alisertib and Fulvestrant in Treating Patients With Hormone Receptor Positive Breast Cancer That is Metastatic or Locally Advanced and Cannot Be Removed by Surgery Start of enrollment: 2014 Dec 05
COMPLETED
PHASE1
Alisertib With or Without Fulvestrant in Treating Patients With Locally Advanced or Metastatic, Endocrine-Resistant Breast Cancer Start of enrollment: 2017 Jul 06
COMPLETED
PHASE2

Publications & Presentations

PubMed

1 citations
Beyond maximum grade: the role of real-world digital health technologies to capture, predict, and manage treatment toxicity in haematological cancers.
Tarec Christoffer El-Galaly, Irène Buvat, Raul Córdoba, Matteo G Della Porta, Jan Geissler
The Lancet. Haematology. 2026-09-01
WeCare intervention to improve breast cancer screening and research preparedness in rural and low-socioeconomic women: study protocol for a community-engaged feasibili...
Pravesh Sharma, Kaylynn G Imsande, Anni Vitriago, Maria Seibel, Joshua C Pritchett
BMJ Open. 2026-06-01
Protocol for Neuro-Oncology Anywhere: Deploying Mayo Clinic's remote cognitive assessment battery and wearable device monitoring platform while assessing the impact of...
Ugur Sener, Bryan Neth, Taylor Galloway, Heather Hughes, Samantha Caron
Contemporary Clinical Trials Communications. 2026-06-01

Journal Articles

Smoking and quality of life among survivors of breast, colorectal and endometrial cancers in a prospective cohort study
Jang S, Prizment A, Haddad T, Robien K, Lazovich D, J Cancer Surviv, 1/1/2011
Nonpharmacologic Complementary Therapies for Symptom Management in Breast Cancer Survivors
Blaes A, Kreitzer MJ, Torkelson C, Haddad T, Semin Oncol, 1/1/2011
Conflict of interest in economic analysis of aromatase inhibitors in breast cancer: a systematic review
Jang S, Chae YK, Haddad T, and Majhail N, Breast Cancer Res Treat, 1/1/2010

Abstracts/Posters

New-Onset Heart Failure in Association with Severe Hypertension During Trastuzumab Therapy.
Herrmann J, Herrmann SM, and Haddad TC, Mayo Clin Proc, 1/1/2014

Lectures

Impact of a cognitive computing clinical trial matching system in an ambulatory oncology practice.
2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018

Press Mentions

Mayo Clinic Leads 4 Decades of Advances in Breast Cancer CareOctober 2nd, 2025
Mayo Clinic Experts Present Key Cancer Research Findings at ASCOMay 28th, 2025
Metastatic Breast Cancer Treatment: Diagnosis to Follow-UpMay 15th, 2025

Grant Support

Evaluation of a novel remote patient monitoring program for cancer patients initiating cancer-directed therapy: The SHIELD (Smart Health Integration for Early Life-saving Detection)MAYO CLINIC ROCHESTER2026–2028